Clinical Trial Update: Safety of Reduced Dose Zidovudine (AZT) Compared With Standard Dose AZT in Antiretroviral-naïve HIV-infected Patients [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update comparing safety of reduced-dose zidovudine versus standard-dose AZT in antiretroviral-naïve HIV-infected patients across Phase 2 and Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Zidovudine (AZT) (Zidovudine)

Snippet

Sponsor: University Hospital, Geneva | Conditions: HIV, Zidovudine Adverse Reaction | Phase 2, Phase 3 | Status: UNKNOWN